You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Harvard Business School
Boehringer Ingelheim
Baxter
Dow

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Clonidine - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for clonidine and what is the scope of freedom to operate?

Clonidine is the generic ingredient in nine branded drugs marketed by Boehringer Ingelheim, Actavis Labs Ut Inc, Aveva, Mayne Pharma, Mylan Technologies, Tris Pharma Inc, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, Xgen Pharms, Zydus Pharms, Mylan Institutional, Actavis Elizabeth, Ajanta Pharma Ltd, Amneal Pharms Ny, Anchen Pharms, Jubilant Generics, Lupin Ltd, Mayne Pharma Inc, Novast Labs, Upsher Smith Labs, Xiamen Lp Pharm Co, Concordia Pharms Inc, Alembic Pharms Ltd, Am Therap, Aurobindo Pharma Ltd, Chartwell Molecules, Duramed Pharms Barr, Frontida Biopharm, Impax Labs, Interpharm, Mylan, Par Pharm, Prinston Inc, Sun Pharm Inds Inc, Teva, Unichem, Warner Chilcott, Watson Labs, and Yung Shin Pharm, and is included in sixty-four NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Clonidine has twenty-one patent family members in fourteen countries.

There are twenty-two drug master file entries for clonidine. Four suppliers are listed for this compound.

Drug Prices for clonidine

See drug prices for clonidine

Drug Sales Revenue Trends for clonidine

See drug sales revenues for clonidine

Recent Clinical Trials for clonidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Health Network, TorontoPhase 3
The Ottawa HospitalPhase 3
Ottawa Hospital Research InstitutePhase 3

See all clonidine clinical trials

Pharmacology for clonidine
Medical Subject Heading (MeSH) Categories for clonidine
Paragraph IV (Patent) Challenges for CLONIDINE
Tradename Dosage Ingredient NDA Submissiondate
CATAPRES-TTS-2 FILM, EXTENDED RELEASE;TRANSDERMAL clonidine 018891
CATAPRES-TTS-3 FILM, EXTENDED RELEASE;TRANSDERMAL clonidine 018891
CATAPRES-TTS-1 FILM, EXTENDED RELEASE;TRANSDERMAL clonidine 018891

US Patents and Regulatory Information for clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 090873-003 May 6, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Par Pharm CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070461-001 Jul 8, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Anchen Pharms CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 202983-002 Apr 2, 2014 DISCN No No   Start Trial   Start Trial   Start Trial
Frontida Biopharm CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070923-001 Sep 4, 1987 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim CATAPRES-TTS-3 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-003 Oct 10, 1984   Start Trial   Start Trial
Boehringer Ingelheim CATAPRES-TTS-1 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-001 Oct 10, 1984   Start Trial   Start Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984   Start Trial   Start Trial
Boehringer Ingelheim CATAPRES-TTS-2 clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 018891-002 Oct 10, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.